Published in Br J Ophthalmol on March 01, 1998
Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol (1999) 2.45
Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br J Ophthalmol (2001) 1.92
Amniotic membrane transplantation. Br J Ophthalmol (1999) 1.82
Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment. Br J Ophthalmol (2000) 1.37
Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br J Ophthalmol (2000) 1.34
Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency. Br J Ophthalmol (2000) 1.33
Amniotic membrane transplantation for partial limbal stem cell deficiency. Br J Ophthalmol (2001) 1.30
Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision. Br J Ophthalmol (2006) 1.17
Failure of amniotic membrane transplantation in the treatment of acute ocular burns. Br J Ophthalmol (2001) 1.11
Reconstruction of the corneal epithelium with induced marrow mesenchymal stem cells in rats. Mol Vis (2010) 1.07
Amniotic membrane grafts, "fresh" or frozen? A clinical and in vitro comparison. Br J Ophthalmol (2001) 0.96
Comparison of intact and denuded amniotic membrane as a substrate for cell-suspension culture of human limbal epithelial cells. Graefes Arch Clin Exp Ophthalmol (2006) 0.95
On the influence of neutrophils in corneas with necrotizing HSV-1 keratitis following amniotic membrane transplantation. Exp Eye Res (2007) 0.94
Bacterial contamination of amniotic membrane. Br J Ophthalmol (2001) 0.92
Effects of octreotide acetate and amniotic membrane on wound healing in experimental glaucoma surgery. Doc Ophthalmol (2003) 0.90
Management of severe ocular burns with symblepharon. Graefes Arch Clin Exp Ophthalmol (2008) 0.90
Separate limbal-conjunctival autograft transplantation using the inferior conjunctiva for primary pterygium. Oman J Ophthalmol (2011) 0.88
[Amniotic membrane transplantation. An indispensable therapy option for persistent corneal epithelial defects]. Ophthalmologe (2007) 0.86
Minimal conjunctival limbal autograft for total limbal stem cell deficiency. Cornea (2008) 0.85
Mitomycin C, amniotic membrane transplantation and limbal conjunctival autograft for treating multirecurrent pterygia with symblepharon and motility restriction. Graefes Arch Clin Exp Ophthalmol (2005) 0.84
Amniotic membrane transplantation for ocular disease: a review of the first 233 cases from the UK user group. Br J Ophthalmol (2007) 0.83
Sutureless amniotic membrane transplantation combined with narrow-strip conjunctival autograft for pterygium. Int Ophthalmol (2011) 0.81
Conjunctival autograft for pterygium. Cochrane Database Syst Rev (2016) 0.81
Rate of epithelialisation and re-operations in corneal ulcers treated with amniotic membrane transplantation combined with botulinum toxin-induced ptosis. Graefes Arch Clin Exp Ophthalmol (2007) 0.81
Amniotic membrane in oral and maxillofacial surgery. Oral Maxillofac Surg (2012) 0.79
Developments and current approaches in the treatment of pterygium. Int Ophthalmol (2016) 0.78
Amnion and Chorion Membranes: Potential Stem Cell Reservoir with Wide Applications in Periodontics. Int J Biomater (2015) 0.77
Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial. Graefes Arch Clin Exp Ophthalmol (2016) 0.77
Periocular Basal Cell Carcinoma Predictors for Recurrence and Infiltration of the Orbit. J Craniofac Surg (2016) 0.75
Conjunctival reconstruction with progenitor cell-derived autologous epidermal sheets in rhesus monkey. PLoS One (2011) 0.75
Astigmatic changes following pterygium removal: comparison of 5 different methods. Indian J Ophthalmol (2013) 0.75
Pre- and intraoperative mitomycin C for recurrent pterygium associated with symblepharon. Clin Ophthalmol (2013) 0.75
Long-term outcome of allogeneic cultivated limbal epithelial transplantation for symblepharon caused by severe ocular burns. BMC Ophthalmol (2017) 0.75
A novel application of amniotic membrane in patients with bullous keratopathy. J Korean Med Sci (2006) 0.75
Culture of Oral Mucosal Epithelial Cells for the Purpose of Treating Limbal Stem Cell Deficiency. J Funct Biomater (2016) 0.75
Amniotic membrane-assisted trabeculectomy for refractory glaucoma with corneal disorders. Int Med Case Rep J (2016) 0.75
Mucous membrane grafting for the post-Steven-Johnson syndrome symblepharon: a case report. Indian J Ophthalmol (2011) 0.75
Long-term follow-up of transplantation of preserved limbal allograft and amniotic membrane for recurrent pterygium. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
[Treatment of severe recurrent symblepharopterygium: combined ipsilateral autologous limbus and homologous amniotic membrane transplantation]. Ophthalmologe (2014) 0.75
Long-term outcome of amniotic membrane transplantation combined with mitomycin C for conjunctival reconstruction after ocular surface squamous neoplasia excision. Int Ophthalmol (2016) 0.75
Characterization of the corneal surface in limbal stem cell deficiency and after transplantation of cultured allogeneic limbal epithelial cells. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Conjunctival autograft versus amniotic membrane transplantation for treatment of pterygium: findings from a Cochrane Systematic Review. Am J Ophthalmol (2017) 0.75
Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology (1992) 6.62
Limbal autograft transplantation for ocular surface disorders. Ophthalmology (1989) 3.56
Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol (1996) 3.40
Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology (1985) 2.97
Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology (1997) 2.80
Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol (1997) 2.41
Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet (1981) 2.23
Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol (1995) 2.04
Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol (1988) 1.81
Autologous nasal mucosa transplantation in severe bilateral conjunctival mucus deficiency syndrome. Ophthalmology (1990) 1.67
Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells. Nature (1982) 1.57
Endometrial cell adhesion in an in vitro model using intact amniotic membranes. Fertil Steril (1996) 1.50
The use of low-dose mitomycin C for prevention of recurrent pterygium. Ophthalmology (1994) 1.36
Corneal stem cell disease: concepts, categorization, and treatment by auto- and homotransplantation of limbal stem cells. CLAO J (1994) 1.34
The amnion in surgery, past and present. Am J Obstet Gynecol (1979) 1.32
Limbal autograft reconstruction after conjunctival squamous cell carcinoma. Am J Ophthalmol (1990) 1.31
Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy. Am J Ophthalmol (1991) 1.28
Human amniotic membrane as a physiologic wound dressing. Arch Surg (1974) 1.26
Conjunctival autografting in the surgical management of pterygium. Eye (Lond) (1993) 1.25
Microanatomy of the human amniotic membranes. A light microscopic, transmission, and scanning electron microscopic study. Am J Obstet Gynecol (1978) 1.25
Keratoepithelioplasty. Am J Ophthalmol (1984) 1.19
Amniotic membrane as a cover for microskin grafts. Br J Plast Surg (1995) 1.15
Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. Br J Ophthalmol (1996) 1.12
Limbal autograft transplantation for recurrent and advanced pterygia. Ophthalmic Surg Lasers (1996) 1.10
The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. J Immunol (1995) 1.05
Subconjunctival fibrosis after conjunctival autograft. Cornea (1993) 1.03
Evaluation of amniotic membrane as adhesion prophylaxis in a novel surgical gastroschisis model. J Invest Surg (1994) 1.00
Use of human amniotic membrane in otolaryngologic practice. Laryngoscope (1987) 0.98
Single dosage of mitomycin C for prevention of recurrent pterygium: preliminary report. Cornea (1994) 0.98
Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Ophthalmology (1995) 0.91
Use of amnion for the treatment of Stevens-Johnson syndrome. J Trauma (1986) 0.86
The use of amniotic membrane plus heparin to prevent postoperative adhesions in the rabbit. Tokai J Exp Clin Med (1993) 0.82
Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis (2008) 3.77
Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol (1996) 3.40
Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med (1999) 2.52
Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology (1997) 2.32
Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol (1995) 2.21
Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjögren's syndrome. Lancet (2001) 2.10
Dry eyes and video display terminals. N Engl J Med (1993) 1.82
Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol (1995) 1.73
Lack of evidence for an increased microchimerism in the circulation of patients with Sjögren's syndrome. Ann Rheum Dis (2001) 1.68
Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea (2001) 1.65
Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology (1995) 1.64
Ocular fatigue is the major symptom of dry eye. Acta Ophthalmol (Copenh) (1993) 1.63
Blinking is controlled primarily by ocular surface conditions. Am J Ophthalmol (1997) 1.57
Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant (2003) 1.55
Biopsy of labial salivary glands and lacrimal glands in the diagnosis of Sjögren's syndrome. J Rheumatol (1996) 1.55
Posterior corneal protrusion after PRK. Cornea (1997) 1.52
Practical double vital staining for ocular surface evaluation. Cornea (1993) 1.50
Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology (1998) 1.49
Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis. Ophthalmology (1995) 1.48
Dry eye after laser in situ keratomileusis. Am J Ophthalmol (2001) 1.46
Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am J Ophthalmol (2001) 1.45
Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia (2010) 1.42
Abnormal blinking of newscasters. Lancet (1999) 1.41
Important concepts for treating ocular surface and tear disorders. Am J Ophthalmol (1997) 1.40
The importance of the Schirmer test with nasal stimulation. Am J Ophthalmol (1991) 1.39
Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye. Cornea (1999) 1.30
Tear function index. A new measure of dry eye. Arch Ophthalmol (1995) 1.30
Trabeculectomy with the use of amniotic membrane for uncontrollable glaucoma. Ophthalmic Surg Lasers (1998) 1.27
Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol (1999) 1.26
A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci (2001) 1.25
Decrease in corneal sensitivity and change in tear function in dry eye. Cornea (1996) 1.17
Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea (2001) 1.13
Intact corneal epithelium is essential for the prevention of stromal haze after laser assisted in situ keratomileusis. Br J Ophthalmol (2001) 1.13
Limbal autograft transplantation for recurrent and advanced pterygia. Ophthalmic Surg Lasers (1996) 1.10
The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis. Allergy (2007) 1.08
Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10. J Immunol (1999) 1.08
Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome. J Clin Lab Anal (1993) 1.07
Adenocarcinoma of the ciliary body pigment epithelium in a child. Arch Ophthalmol (1984) 1.06
Dry eye after refractive surgery. Curr Opin Ophthalmol (2001) 1.06
Thermal effect on corneal incisions with different phacoemulsification ultrasonic tips. J Cataract Refract Surg (1999) 1.06
Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone Marrow Transplant (2007) 1.05
Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts. Clin Exp Immunol (1998) 1.04
Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device. Br J Ophthalmol (2002) 1.04
Frequency of consanguineous marriages in Japan: geographical variations. Jinrui Idengaku Zasshi (1984) 1.03
Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. Cornea (2001) 1.02
Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol (1999) 1.00
Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome. J Clin Invest (1996) 1.00
Excimer laser-induced hydroxyl radical formation and keratocyte death in vitro. Invest Ophthalmol Vis Sci (1999) 0.99
Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis. Allergy (2008) 0.99
Decreased tear lipocalin concentration in patients with meibomian gland dysfunction. Br J Ophthalmol (2005) 0.99
Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: a preliminary study. Cornea (1996) 0.98
Correlation of tear clearance rate and fluorophotometric assessment of tear turnover. Br J Ophthalmol (1995) 0.97
Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome. Ophthalmology (2000) 0.97
Clinical features of a newly recognized type of lattice corneal dystrophy. Am J Ophthalmol (1987) 0.97
Measurement of fornix depth and area: a novel method of determining the severity of fornix shortening. Eye (Lond) (2008) 0.96
Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235. Br J Ophthalmol (2002) 0.95
Elucidation of apoptosis induced by serum deprivation in cultured conjunctival epithelial cells. Br J Ophthalmol (2006) 0.95
Corneal temperature in patients with dry eye evaluated by infrared radiation thermometry. Br J Ophthalmol (1996) 0.95
Corneal endothelial cell loss induced by air bags. Ophthalmology (1993) 0.95
Morphology and barrier function of the corneal epithelium after penetrating keratoplasty: association with original diseases, tear function, and suture removal. Cornea (1999) 0.95
Subthreshold UV radiation-induced peroxide formation in cultured corneal epithelial cells: the protective effects of lactoferrin. Exp Eye Res (1996) 0.94
Formation of dioxins (PCDDs/PCDFs) by dioxin-free fly ash as a catalyst and relation with several chlorine-sources. Chemosphere (2000) 0.94
Effect of laser in situ keratomileusis correction on contrast visual acuity. J Cataract Refract Surg (2001) 0.94
Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye. Bone Marrow Transplant (2009) 0.93
Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea (1996) 0.92
Pterygium and dry eye. Ophthalmologica (2001) 0.92
Allergic conjunctivitis and dry eye. Br J Ophthalmol (1996) 0.92
Poor illumination, VDTs, and desiccated eyes. Lancet (1996) 0.91
Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112. Am J Ophthalmol (1995) 0.91
Cytologic evaluation of conjunctival epithelium using Cytobrush-S: value of slide preparation by ThinPrep technique. Cytopathology (1997) 0.91
Alterations of the tear film and ocular surface health in chronic smokers. Eye (Lond) (2008) 0.91
Preferential localization of CD8+ alpha E beta 7+ T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome. J Immunol (1999) 0.91
Trabeculectomy with mitomycin C for post-keratoplasty glaucoma. Br J Ophthalmol (2000) 0.90
Long-term follow-up of patients with familial subepithelial amyloidosis of the cornea. Ophthalmology (1995) 0.90
Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Immunol (1995) 0.90
Quantitative evaluation of atopic blepharitis by scoring of eyelid conditions and measuring the water content of the skin and evaporation from the eyelid surface. Cornea (2001) 0.90
Prevalence of migraine and Raynaud's phenomenon in Japanese patients with vasospastic angina. Jpn Circ J (2000) 0.90
Iatrogenic cataract after laser-assisted in situ keratomileusis. Am J Ophthalmol (1999) 0.90
Lacrimal punctal occlusion for the treatment of superior limbic keratoconjunctivitis. Am J Ophthalmol (1997) 0.89
Inbreeding in Japan: Results of a nation-wide study. Jinrui Idengaku Zasshi (1975) 0.89
pH changes of self-etching primers mixed with powdered dentine. J Dent (2008) 0.89
Detection of hepatitis C virus RNA in tears and aqueous humor. Am J Ophthalmol (1994) 0.89
Measurement of cytoplasmic viscosity by fluorescence polarization in phytohemagglutinin-stimulated and unstimulated human peripheral lymphocytes. J Histochem Cytochem (1988) 0.88
Intraoperative versus postoperative suture adjustment after penetrating keratoplasty. Cornea (1998) 0.88
Alterations of the ocular surface epithelial mucins 1, 2, 4 and the tear functions in patients with atopic keratoconjunctivitis. Clin Exp Allergy (2006) 0.88
Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0. 12% unoprostone. Br J Ophthalmol (2000) 0.88
Telomerase activity and p53 expression in pterygia. Invest Ophthalmol Vis Sci (2000) 0.87
Immunohistological analysis of tumour growth factor beta 1 expression in normal and inflamed salivary glands. J Clin Pathol (1996) 0.87